Swiss Parenterals Limited

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Swiss Parenterals Limited - overview

Established

1986

Location

Ahmedabad, Gujarat, India

Primary Industry

Pharmaceuticals

About

Based in Gujarat, India, and founded in 1986, Swiss Parenterals Limited, operates as a generic and specialty drug manufacturer and provider of machinery and infrastructure at the manufacturing units. In February 2024, Eris Lifesciences Limited, a portfolio company of ChrysCapital and Kuwait Investment Authority, agreed to acquire a 51% majority stake in Swiss Parenterals for INR 6. 37 billion. As of 2024, the company is led by its director, Naishadh Shah.


The company offers regular and complex dosage forms, catering to a wide range of medical needs. The company provides a range of injectables that include parenterals, inhaled anasthesia, ophthalmic and nasal, orals, semi-solids, nutritional (OTC), and many more. Following the February 2024 acquisition, the company plans to bolster the company's domestic presence with a new injectables-focused branded formulations business and enhance its reach in emerging markets.


Current Investors

Eris Lifesciences Limited

Primary Industry

Pharmaceuticals

Sub Industries

Medical Supplies, Specialty Pharmaceuticals, Pharmaceutical Research & Development

Website

www.swiss.in/

Verticals

Manufacturing

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Swiss Parenterals Limited - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-onCompletedSwiss Parenterals Limited-

Displaying 1 - 1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.